Massive Institutional Buying HGSI 500,00 Share Big Block Trades
Date: 3/1/2011
Massive Institutional Buying HGSI 500,00 Share Big Block Trades. Stock Trading Video All Eyes on Human Genome Sciences Benlysta FDA Decision. BENLYSTA®: FDA Approval Recommended by Advisory Committee; PDUFA Target Date for FDA Decision Extended to March 10, 2011 HGSI Human Genome Sciences FDA, HGSI Human Genome Sciences FDA Human Genome Sciences Benlysta® Drug Approval for Lupus Patients. Human Genome Sciences (NASDAQ Symbol: HGSI) trading video and FDA Benlysta Approval Analysis ahead of the 3/10/2011 FDA decision.
Analyst Coverage Human Genome Sciences (NASDAQ:HGSI):
2/25 – Baird maintains outperform, price target of $32.00
2/25 – Stifel Nicolaus maintains buy, price target of $38.00
2/25 – JMP Securities maintains market outperform, price target of $45.00
2/25 – Lazard maintains buy, price target of $31.00
2/25 – Gleacher & Co. maintains buy, price target of $30.00
2/25 – Piper Jaffrey maintains overweight, price target lowered to $32.00 (from $33.00 the previous week)
2/25 – Collins Stewart maintains buy, price target of $37.00
2/25 – Barclays maintains overweight/positive, price target of $40.00
2/24 – RBC Capital maintains outperform, price target of $38.00
2/24 – JPMorgan maintains overweight, price target lowered to $37.00 (from $38.00)
2/24 – Leerink Swann maintains outperform, price target of $35.00
Video categories: "HGSI Benlysta" "Benlysta HGSI" "human genome sciences" "FDA Benlysta" "Benlysta FDA" Video on: HGSI Human Genome Sciences FDA Panel Review Selling Rumors Speculation Benlysta Drug Approval Lupus Patients Special Biotech Future Video SMF Reiterates Strong Buy Rating trading stock stocks "the stock market" biotechnology "biotech stocks" drug drugs "drug companies" pharmaceutical lupis "lupis drug" "drug lupis" "FDA approval" "Benlysta Drug" "hgsi benlysta" "benlysta hgsi" takeover GSK "hgsi takeover target" "Benlysta FDA" "HGSI fda" "fda hgsi" suicide risks "hgsi stock"